ArticleChinese journal of cancer2017
Mortality outcomes of low-dose computed tomography screening for lung cancer in urban China: a decision analysis and implications for practice.
Article in Chinese journal of cancer, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed, 30 citations in OpenAlex.
- Influencing factors of low-dose computed tomography screening behavior among first-degree relatives of lung cancer patients based on the theory of planned behavior: a qualitative study.Frontiers in public health · 2026Article
- Cost-effectiveness of chest radiography using artificial intelligence for lung cancer screening in South Korea.Scientific reports · 2025Article
- Cost effectiveness analysis of low dose computed tomography lung cancer screening in Chinese population.Scientific reports · 2025Article
- Non‑diagnostic electromagnetic navigation bronchoscopy biopsy: Predictive factors and final diagnoses.Oncology letters · 2023Article
- Disparity in Lung Cancer Screening Among Smokers and Nonsmokers in China: Prospective Cohort Study.JMIR public health and surveillance · 2023Article
- A multidimensional model incorporating radiomics score and liquid biopsy for the prediction of malignant and benign pulmonary nodules.Translational cancer research · 2022Article
- Development and validation of qualitative and quantitative models to predict invasiveness of lung adenocarcinomas manifesting as pure ground-glass nodules based on low-dose computed tomography during lung cancer screening.Quantitative imaging in medicine and surgery · 2022Article
- Barriers and facilitators of lung cancer screening uptake: protocol of a mixed methods systematic review.BMJ open · 2022Article
- Adaptation and validation of the Chinese version of the lung cancer screening health belief scales.BMC public health · 2022Article
- Improved detection of solitary pulmonary nodules on radiographs compared with deep bone suppression imaging.Quantitative imaging in medicine and surgery · 2021Article
- Determining cost-effectiveness of lung cancer screening in urban Chinese populations using a state-transition Markov model.BMJ open · 2021Article
- Lung cancer LDCT screening and mortality reduction - evidence, pitfalls and future perspectives.Nature reviews. Clinical oncology · 2021Review
- The challenges of implementing low-dose computed tomography for lung cancer screening in low- and middle-income countries.Nature cancer · 2020Review
- [Research Progress on Lung Cancer Screening].Zhongguo fei ai za zhi = Chinese journal of lung cancer · 2020Review
- Preoperative diagnosis of malignant pulmonary nodules in lung cancer screening with a radiomics nomogram.Cancer communications (London, England) · 2020Article
- Feasibility of lung cancer screening in developing countries: challenges, opportunities and way forward.Translational lung cancer research · 2019Review
- Implementation planning for lung cancer screening in China.Precision clinical medicine · 2019Review
- Methods of computed tomography screening and management of lung cancer in Tianjin: design of a population-based cohort study.Cancer biology & medicine · 2019Article
- Challenges and research opportunities for lung cancer screening in China.Cancer communications (London, England) · 2018Article
- A national survey of lung cancer specialists' views on low-dose CT screening for lung cancer in Korea.PloS one · 2018Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMortality outcomes in trials of low-dose computed tomography (CT) screening for lung cancer are inconsistent. This study aimed to evaluate whether CT screening in urban areas of China could reduce lung cancer mortality and to investigate the factors that associate with the screening effect.
methodsA decision tree model with three scenarios (low-dose CT screening, chest X-ray screening, and no screening) was developed to compare screening results in a simulated Chinese urban cohort (100,000 smokers aged 45-80 years). Data of participant characteristics were obtained from national registries and epidemiological surveys for estimating lung cancer prevalence. The selection of other tree variables such as sensitivities and specificities of low-dose CT and chest X-ray screening were based on literature research. Differences in lung cancer mortality (primary outcome), false diagnoses, and deaths due to false diagnosis were calculated. Sensitivity analyses were performed to identify the factors that associate with the screening results and to ascertain worst and optimal screening effects considering possible ranges of the variables.
resultsAmong the 100,000 subjects, there were 448, 541, and 591 lung cancer deaths in the low-dose CT, chest X-ray, and no screening scenarios, respectively (17.2% reduction in low-dose CT screening over chest X-ray screening and 24.2% over no screening). The costs of the two screening scenarios were 9387 and 2497 false diagnoses and 7 and 2 deaths due to false diagnosis among the 100,000 persons, respectively. The factors that most influenced death reduction with low-dose CT screening over no screening were lung cancer prevalence in the screened cohort, low-dose CT sensitivity, and proportion of early-stage cancers among low-dose CT detected lung cancers. Considering all possibilities, reduction in deaths (relative numbers) with low-dose CT screening in the worst and optimal cases were 16 (5.4%) and 288 (40.2%) over no screening, respectively.
conclusionsIn terms of mortality outcomes, our findings favor conducting low-dose CT screening in urban China. However, approaches to reducing false diagnoses and optimizing important screening conditions such as enrollment criteria for screening are highly needed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.